[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Danni Feng\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":4},"100536997","postoperative-wounds-with-delayed-healing-risk-of-clinical-trial-registration-100536997",false,"NCT06272097","Postoperative Wounds With Delayed Healing Risk of Clinical Trial Registration","Optimization Program for the Care Management of Wounds With Delayed Healing Risk After Hip Arthroplasty Based on TIME CDST Tool: a Randomized Controlled Trial Protocol","Inclusion Criteria:\n\n* age ≥18 years;\n* First-time recipient of unilateral total HA or hemiarthroplasty;\n* Postoperative wound healing delay risk, defined as epithelialization \\\u003C50% at 2 weeks postoperatively (quantified using a standardized manual planar measurement method: on day 14 postoperatively, a (quantified using a standardized manual planar measurement method: on day 14 postoperatively, a standardized transparent grid membrane with 1mm² graduations is placed vertically over the wound, and the wound perimeter and epithelialization boundary are marked with a surgical marker. boundary are marked with a surgical marker pen; the epithelialized area is defined as pink, non-exudative tissue completely covering the dermis); Normal cognitive and communication abilities;\n* Ability to comply with relevant nursing measures;\n* Voluntary participation in this trial\n* Voluntary participation in this trial and signed informed consent form.\n\nExclusion Criteria:\n\n* Active infection at the surgical site prior to initial hip surgery; Deep surgical site infection (SSI) or periprosthetic joint infection (PJI) diagnosed or strongly suspected at screening. diagnosed or strongly suspected at screening (based on clinical symptoms, imaging, or aspiration results according to the MSIS\u002FEBJIS criteria);\n* Complete wound dehiscence (\\>2 cm) or exposure of the prosthesis\u002Fbone cement, requiring emergency revision surgery;\n* Severe vascular insufficiency (ABI \\\u003C0.5 cm);\n* Severe acute and chronic chronic disease (ABI \\\u003C0.5 cm) insufficiency (ABI \\\u003C0.6, severe limb ischemia);\n* Uncontrolled systemic conditions severely impairing healing potential: severe malnutrition or obesity (BMI≥ 40 kg\u002Fm² or≤ 16 kg\u002Fm² or serum albumin \\\u003C2.5 g\u002FdL); Uncontrolled diabetes (HbA1c \\>9% in the past 3 months); severe heart failure (NYHA IV); severe liver dysfunction (Child-Pugh C); severe renal failure requiring dialysis; active malignant tumors; immunosuppressive therapy (high-dose corticosteroids \\>10 mg prednisolone); and dose corticosteroids \\>10 mg prednisone equivalent\u002Fday, biologics, or immunosuppressive agents following transplantation).","ALL","18 Years",{"count":19,"type":20},492,"ESTIMATED","INTERVENTIONAL",[23],"NA","this study aims to optimize the components of TIME CDST based on clinical practice and apply the optimized elements to the management of wounds with delayed healing risk after hip arthroplasty to identify and design the key steps in the clinical application of TIME CDST. Through a randomized controlled trial approach, the investigators will conduct a rigorous comparative analysis of the experimental group and the control group. The intervention group will receive an intervention plan based on the TIME CDST tool led by wound specialist nurses at each dressing change, while the control group receive a routine wound care program of wound cleaning and dressing changes at each dressing change. The main research objective is to evaluate the superiority of the experimental group compared with the control group in terms of wound healing time, healing quality, and patient satisfaction. Through the implementation of this study, the investigators expect to provide an effective optimization scheme for the management of postoperative wounds with delayed healing risk in clinical practice, thereby improving patient outcomes and quality of life.",[26],"Wound Heal","NOT_YET_RECRUITING","2025-07-21",{"date":30,"type":31},"2025-07-25","ACTUAL",{"date":33,"type":20},"2025-12-31",{"date":35,"type":20},"2028-12-31",{"name":37,"class":38},"Danni Feng","OTHER",""]